Loading organizations...

§ Private Profile · Cambridge, MA, USA
Healthcare AI platform automating prior authorization, utilization management, and medical reviews for health plans and providers.
Based in Somerville, Massachusetts, basys.ai is a healthcare technology company developing an artificial intelligence platform to automate prior authorization, utilization management, and medical reviews for health plans and providers. Founded in 2022 by Amber Nigam and Jie Sun out of Harvard University, the company utilizes generative AI and multi-agent models trained on clinical data from over 10 million patients to streamline administrative workflows and encode payer policies. Operating under a B2B software licensing model, the firm provides its technology to health insurance companies, hospital systems, and federal organizations to reduce decision turnaround times and improve patient access. The enterprise secured $2.4 million in seed funding from a syndicate of venture capital investors and strategic partners including Nina Capital, Mayo Clinic, Eli Lilly, and CareFirst. The organization also received top recognition from CMS for targeting fraud, waste, and abuse.
basys.ai has raised $2.4M across 1 funding round.
basys.ai has raised $2.4M in total across 1 funding round.
basys.ai has raised $2.4M in total across 1 funding round.
basys.ai's investors include Nina Capital, Anna Pouschine, Aylit Schultz, Emily Counceller, Greg Buchert, Hashim Salman, Ho Anh, James Roosevelt, Jianming Yu, Jie Sun, John Brooks, John Harthorne.
basys.ai has raised $2.4M across 1 funding round. Most recently, it raised $2.4M Pre-Seed in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 10, 2023 | $2.4M Pre Seed | Nina Capital | Anna Pouschine, Aylit Schultz, Emily Counceller, Greg Buchert, Hashim Salman, HO ANH, James Roosevelt, Jianming YU, JIE SUN, John Brooks, John Harthorne, Lily Toto, Luke Armour, Marta G. Zanchi, Michal Gilon Yanai, Mohammad Elias, Paul Kudlow, Peter Moran, Sebastian Anastassiou, Skip Fleshman, Asset Management Ventures, Chaac Ventures, ELI Lilly And Company, Mayo Clinic, TWO Lanterns Venture Partners | Announced |